Plectin promotes an aggressive phenotype and represses cytotoxic T cell activity in pancreatic cancer
Cody L. Wolf, Roxanne K. Ruiz, Sokchea Khou…·Kimberly A. Kelly
This study identifies plectin as a biomarker of aggressive pancreatic cancer, showing it suppresses T cell activity and that targeting it with an antibody enhances anti-tumor immunity.